Spence Paul Jr. 4
4 · OptiNose, Inc. · Filed Feb 26, 2025
Insider Transaction Report
Form 4
OptiNose, Inc.OPTN
Spence Paul Jr.
Chief Commercial Officer
Transactions
- Award
Common Stock
2025-02-21+17,025→ 33,870 total - Award
Stock Option (Right to Buy)
2025-02-21+8,525→ 8,525 totalExercise: $5.77Exp: 2035-02-21→ Common Stock (8,525 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units (RSUs). Twenty-five percent (25%) of the RSUs vest on February 21, 2026, and the balance vests in equal quarterly installments over the remaining three years of the four year period, subject to continued service with the Issuer. Each RSU represents the right to receive one share of common stock of OptiNose, Inc.
- [F2]The option vests and becomes exercisable over a four-year period commencing on February 21, 2025. Twenty-five percent (25%) of the option vests and becomes exercisable on February 21, 2026, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer.